Últimas noticias sobre Dingdong (Cayman) (NYSE:DDL) Bolsa

Dingdong (Cayman)

Dingdong (Cayman) Ltd is the fastest growing on-demand e-commerce company in China. The company directly provides users and households with fresh produce, meat and seafood, and other daily necessities through a convenient shopping experience supported by an extensive self-operated frontline fulfillment grid. It recognizes revenues from product sales of fresh groceries and other daily necessities through Dingdong Fresh APP and mini-programs and membership services.

Dingdong (Cayman) Limited American Depositary Shares (each two representing three Ordinary Shares)

Dingdong (Cayman) Ltd

WisdomTree Dynamic International SmallCap Equity Fund

Piper Sandler analyst Matt O'Brien maintains DexCom (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DXCM#NASDAQ">DXCM</a>) with a Overweight and raises the price target from $90 to $100.

News

Price Target

Analyst Ratings

DXCM

Piper Sandler Maintains Overweight on DexCom, Raises Price Target to $100

Silexion continues to prepare for the initiation of a Phase 2/3 clinical trial in Q2 2026 to investigate SIL204 for the treatment of KRAS-driven solid tumor cancers, leveraging both intratumoral and systemic delivery approaches as part of the Company's dual-route administration strategy.
 &nbsp;

SLXN

Silexion Continues To Prepare For Initiation Of Phase 2/3 Clinical Trial In Q2 2026 To Investigate SIL204 For Treatment Of KRAS-Driven Solid Tumor Cancers

Roblox Corp&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RBLX#NYSE">RBLX</a>)&nbsp;stock gained after it reported&nbsp;<a target="_blank" href="https://www.benzinga.com/pressreleases/25/07/b46753136/roblox-reports-second-quarter-2025-financial-results" rel="noreferrer noopener">fiscal second-quarter</a>&nbsp;results on Thursday. The company reported quarterly bookings growth of 51% year-on-year to $1.44 billion, topping the&nbsp;<a target="_blank" href="https://www.benzinga.com/calendars/earnings" rel="noreferrer noopener">analyst consensus estimate</a> of $1.21 billion.
The video game developer reported an EPS loss of 41 cents, which missed the analyst consensus estimate of 36 36-cent loss.
Also Read: <a target="_blank" href="https://www.benzinga.com/markets/large-cap/25/07/46538469/roblox-expands-into-edtech-with-google-bbc-games" rel="noreferrer noopener">Roblox Expands Into EdTech With Google, BBC Games</a>
Revenue of the American video game developer grew by 21% Y/Y to $1.08 billion.
Average Daily Active Users (DAUs) were 111.8 million, up 41% Y/Y. Hours Engaged were 27.4 billion, up 58% Y/Y.
The average monthly number of unique payers was 23.4 million, up 42% year-over-year. The Average Bookings per DAU was $12.86, up 7.0% Y/Y.
For the quarter, Roblox generated $199.3 million in operating cash flow, a significant increase from $151.4 million in the same quarter a year earlier. Free cash flow for the quarter was $176.7 million, up from $111.7 million Y/Y.
Net loss for the quarter was $278.4 million, up from a loss of $205.9 million in the same period last year.
David Baszucki, founder and CEO of Roblox, credited the Y/Y growth to Roblox's continued investments in infrastructure, discovery tools, and the virtual economy—investments that are enabling creators to succeed in a healthy, interconnected ecosystem. He remains encouraged by the broad-based growth and remains focused on capturing 10% of the global gaming content market.
Naveen Chopra, Roblox CFO, highlighted significant growth in daily active users, hours engaged, monthly unique payers, revenue, and bookings as clear indicators of the platform's strength and reach.
Outlook:&nbsp;Roblox&nbsp;expects third-quarter&nbsp;bookings of $1.590 billion-$1.640 billion (versus&nbsp;the&nbsp;<a href="https://www.benzinga.com/calendars/guidance" target="_blank" rel="noreferrer noopener">analyst consensus estimate</a> of&nbsp;$1.330 billion) and fiscal 2025 bookings of $5.870 billion-$5.970 billion (<a href="https://www.benzinga.com/news/earnings/25/05/45141775/why-is-roblox-stock-trading-higher-on-thursday">prior $5.285 billion-$5.360 billion</a>) versus the analyst consensus estimate of $5.360 billion.
Price Action:&nbsp;RBLX stock is up 17.8% to $147.21 at&nbsp;the last check on Thursday.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/earnings/25/07/46722008/garmin-stock-climbs-after-strong-q2-beat-fitness-and-outdoor-sales-surge-mylaps-acquisition" target="_blank" rel="noreferrer noopener">Garmin Stock Climbs After Strong Q2 Beat, Fitness And Outdoor Sales Surge, MYLAPS Acquisition</a></li>
</ul>
Photo: Shutterstock

Earnings

Guidance

RBLX

Roblox Stock Soars 18% After Blowout Q2—User Growth, Bookings Surge, Big Guidance Boost Wow Wall Street

Silexion Therapeutics Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SLXN#NASDAQ">SLXN</a>) ("Silexion" or the "Company"), a clinical-stage biotechnology company pioneering RNA interference (RNAi) therapies for KRAS-driven cancers, today announced groundbreaking new preclinical data revealing unprecedented inhibition rates of up to 97% in pancreatic cancer cells and almost 90% in colorectal cancer cells. These findings, which include the Company's first evidence of efficacy against the clinically significant KRAS Q61H mutation in human cancer cells, represent a substantial advancement from previously reported results and further establish SIL204's potential as a pan-KRAS therapeutic.
While the Company has previously reported activity in various cancer models, these latest findings from a comprehensive CTG (Cell Titer-Glo) analysis demonstrate significantly higher inhibition rates and provide the first direct comparison of SIL204's potency across multiple cancer types and KRAS mutations in a single study, including dose-dependent inhibition of up to 94% in pancreatic cancer cells with KRAS G12D mutations, comparable 97% inhibition in pancreatic cancer cells with the previously untested KRAS Q61H mutation.
Key findings from the preclinical studies include:
<ul>
<li>SIL204 demonstrated dose-dependent inhibition of up to 94% in pancreatic cancer cells harboring KRAS G12D mutations at nanomolar concentrations</li>
<li>SIL204 showed comparable efficacy of approximately 97% inhibition in pancreatic cancer cells with KRAS Q61H mutations, a variant not previously reported in the Company's studies</li>
<li>SIL204 produced an inhibition rate of nearly 90% in colorectal cancer cells with KRAS G12D mutations, extending previous evidence of its effectiveness beyond pancreatic cancer</li>
</ul>
This announcement comes just days after Silexion reported significant efficacy of SIL204 in lung cancer cell lines, validating the Company's innovative lipid-conjugated delivery system. Together, these results across pancreatic, colorectal, and lung cancer models provide comprehensive evidence of SIL204's broad applicability against KRAS-driven cancers.
Silexion continues to prepare for the initiation of a Phase 2/3 clinical trial in Q2 2026 to investigate SIL204 for the treatment of KRAS-driven solid tumor cancers, leveraging both intratumoral and systemic delivery approaches as part of the Company's dual-route administration strategy. &nbsp;

Silexion Therapeutics Announces New Preclinical Data Revealing Unprecedented Inhibition Rates Of Up To 97% In Pancreatic Cancer Cells And Almost 90% In Colorectal Cancer Cells

Despite financial challenges,&nbsp;Donald Trump&#8216;s Scottish golf course is aiming for a comeback.&nbsp;The U.S. President&#8217;s son, Eric Trump, made a bold statement about the financial performance of the family&#8217;s golf course.
<h2 class="wp-block-heading">Despite Millions In Losses, Eric Trump Defends Turnberry As A Passion Project</h2>
Trump recently traveled to Scotland to open a new golf course in Aberdeenshire, on the country's east coast. Acquired by Trump in 2014 for around $60 million and renovated for $144 million, Trump Turnberry has struggled to become profitable.
Despite a loss of $1.7 million in the 2023 fiscal year, as reported by the Washington Post, Eric Trump remains unfazed. &#8220;We don&#8217;t give a damn, right. This is our Mona Lisa. If we spent $100 million and never got a penny back, it doesn&#8217;t make any difference. We wanted to do something incredible,&#8221; he <a href="https://www.bbc.com/sport/golf/articles/c70x49kzwkyo?at_medium=RSS&amp;at_campaign=rss">told </a>BBC Sport on Wednesday.
<h2 class="wp-block-heading">Turnberry&#8217;s Return To &#8216;The Open&#8217; May Hinge On Trump&#8217;s Exit From Politics</h2>
He also expressed confidence in his father&#8217;s passion for the game, suggesting that it could lead to another opportunity to host The Open, a prestigious golf tournament, once Donald Trump is no longer president. Eric Trump suggested that politics may have been a factor in Turnberry&#8217;s recent exclusion as an Open host.
Turnberry, known for hosting the Open Championships, has not been the tournament site since 2009. The head of The R&amp;A, the global golf governing body, announced in 2021 that The Open would not return to Turnberry while Trump was associated with the venue. However, the organization has since been considering a potential return.
<h2 class="wp-block-heading">Fusion of Sports, Politics And Crypto Finance</h2>
Trump&#8217;s visit to Scotland marked his return to a country where he has significant <a href="https://www.benzinga.com/news/politics/25/07/46648558/great-to-be-in-scotland-trump-kicks-off-golf-filled-getaway">personal and business</a> ties. According to ABC News, in 2018, the U.S. federal government incurred close to $70,000 in expenses at the Trump hotel in Turnberry during President Donald Trump&#8217;s visit in his first term.
Interestingly, the inauguration of the new golf course in Aberdeen signals a growing intersection between traditional sports and digital finance, with <a href="https://www.benzinga.com/news/sports/25/07/46708897/trump-inaugurates-new-aberdeen-course-ahead-of-nexo-championship-crypto-lender-eyes-u-s-market-reentry">crypto lender Nexo</a> backing the tournament. This could potentially bring a new wave of investment and interest to the struggling golf course.
READ MORE:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/crypto/cryptocurrency/25/07/46623268/eric-trump-has-an-optimistic-view-on-ethereums-current-value-agrees-eth-should-have-crossed-8000-by-now">Eric Trump Has An Optimistic View On Ethereum&#8217;s Current Value, Agrees ETH Should Have Crossed $8,000 By Now</a></li>
</ul>
Image via Shutterstock
Disclaimer:&nbsp;This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

Trump Turnberry Is 'Our Monalisa' Says Eric Trump As He Shrugs Off  Millions In Losses— 'We Don't Give A...'

UBS analyst Radi Sultan maintains Confluent (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CFLT#NASDAQ">CFLT</a>) with a Buy and lowers the price target from $32 to $28.

CFLT

UBS Maintains Buy on Confluent, Lowers Price Target to $28

Piper Sandler analyst Matt O'Brien maintains Conmed (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CNMD#NYSE">CNMD</a>) with a Overweight and lowers the price target from $80 to $68.

CNMD

Piper Sandler Maintains Overweight on Conmed, Lowers Price Target to $68

UBS analyst Timothy Arcuri maintains ARM Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARM#NASDAQ">ARM</a>) with a Buy and lowers the price target from $185 to $175.

UBS Maintains Buy on ARM Holdings, Lowers Price Target to $175

Piper Sandler analyst Nathan Race maintains UMB Financial (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UMBF#NASDAQ">UMBF</a>) with a Overweight and raises the price target from $135 to $148.

UMBF

Piper Sandler Maintains Overweight on UMB Financial, Raises Price Target to $148

<a href="https://www.wsj.com/livecoverage/stock-market-today-dow-sp-500-nasdaq-07-31-2025-2/card/trump-and-mexico-s-sheinbaum-expected-to-discuss-tariffs-today-GRdq8J3mbpdKyaeGEUt9?mod=Searchresults_pos2&amp;page=1">https://www.wsj.com/livecoverage/stock-market-today-dow-sp-500-nasdaq-07-31-2025-2/card/trump-and-mexico-s-sheinbaum-expected-to-discuss-tariffs-today-GRdq8J3mbpdKyaeGEUt9?mod=Searchresults_pos2&amp;page=1</a>

General

'Trump and Mexico's Sheinbaum Expected to Discuss Tariffs Today'- WSJ

UBS analyst Thomas Wadewitz maintains ArcBest (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARCB#NASDAQ">ARCB</a>) with a Neutral and lowers the price target from $84 to $73.

ARCB

UBS Maintains Neutral on ArcBest, Lowers Price Target to $73

Keybanc analyst Jason Celino maintains PTC (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PTC#NASDAQ">PTC</a>) with a Overweight and raises the price target from $192 to $245.

Keybanc Maintains Overweight on PTC, Raises Price Target to $245

Piper Sandler analyst Mark Fitzgibbon maintains Orange County Bancorp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OBT#NASDAQ">OBT</a>) with a Overweight and lowers the price target from $30 to $29.

Piper Sandler Maintains Overweight on Orange County Bancorp, Lowers Price Target to $29

UBS analyst Dennis Geiger maintains Wingstop (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WING#NASDAQ">WING</a>) with a Neutral and raises the price target from $335 to $385.

WING

UBS Maintains Neutral on Wingstop, Raises Price Target to $385

MACIU

Trading Halt: Halt status updated at 9:50:00 AM ET: Quotation Resumption: News and Resumption Times

Piper Sandler analyst Nathan Race maintains German American Bancorp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GABC#NASDAQ">GABC</a>) with a Neutral and raises the price target from $42 to $44.

GABC

Piper Sandler Maintains Neutral on German American Bancorp, Raises Price Target to $44

Keybanc analyst David Tarantino maintains Modine Manufacturing (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MOD#NYSE">MOD</a>) with a Overweight and raises the price target from $125 to $150.

Keybanc Maintains Overweight on Modine Manufacturing, Raises Price Target to $150

UBS analyst Alberto Valerio maintains Controladora Vuela (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VLRS#NYSE">VLRS</a>) with a Buy and raises the price target from $6 to $8.

VLRS

UBS Maintains Buy on Controladora Vuela, Raises Price Target to $8

Piper Sandler analyst Mark Lear maintains Expand Energy (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EXE#NASDAQ">EXE</a>) with a Overweight and raises the price target from $139 to $140.

Piper Sandler Maintains Overweight on Expand Energy, Raises Price Target to $140

Keybanc analyst Justin Patterson maintains Meta Platforms (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/META#NASDAQ">META</a>) with a Overweight and raises the price target from $800 to $905.

Keybanc Maintains Overweight on Meta Platforms, Raises Price Target to $905

Press Releases

Dingdong (Cayman) Limited Announces Second Quarter 2024 Financial Results

Dingdong to Report Third Quarter 2024 Financial Results on November 6, 2024

Dingdong (Cayman) Limited Announces Third Quarter 2024 Financial Results

Dingdong to Report Fourth Quarter 2024 Financial Results on March 6, 2025

Dingdong Announces US$20.0 Million Share Repurchase Program

Dingdong (Cayman) Limited Announces Fourth Quarter 2024 Financial Results

Dingdong Files Its Annual Report on Form 20-F

Dingdong to Report First Quarter 2025 Financial Results on May 16, 2025

Dingdong (Cayman) Limited Announces First Quarter 2025 Financial Results

Albertsons Companies, Inc. Class A Common Stock

Albertsons Companies

Maplebear

Caseys General Stores, Inc. - Common Stock

Casey's General Stores

Chanson International Holding - Class A Ordinary Shares

Chanson International

Grocery Outlet Holding Corp. - Common Stock

Grocery Outlet Holding

Ingles Markets, Incorporated - Class A Common Stock

Ingles Markets

Kroger

Maison Solutions Inc. - Class A Common Stock

Maison Solutions

Natural Grocers by Vitamin Cottage, Inc. Common Stock

Natural Grocers

Reborn Coffee

Sprouts Farmers Market, Inc. - Common Stock

Sprouts Farmers Market

BBB Foods

Village Super Market, Inc. - Class A Common Stock

Village Super Market

WEBUY GLOBAL LTD. - Class A Ordinary Shares

Webuy Global

Weis Markets

Meiwu Technology Company Limited - Ordinary Shares

Comments

Dingdong (Cayman)

Noticias

Últimas noticias sobre Dingdong (Cayman) (NYSE:DDL) Bolsa

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL